Apollo Endosurgery, Inc. (NASDAQ: APEN) Starts Presentation at 29th Annual ROTH Conference
Apollo Endosurgery (NASDAQ: APEN) is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 500 million people globally, as well as other gastrointestinal disorders. The company’s device based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 80 countries today. For more information, visit the company’s website at www.apolloendo.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution…







